82 results on '"V. Hagen"'
Search Results
2. Adoption of outgroup norms provides evidence for social transmission in perinatal care practices among rural Namibian women
- Author
-
Renée V. Hagen and Brooke A. Scelza
- Subjects
Cultural identity ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,Population ,Medicine (miscellaneous) ,01 natural sciences ,Conformity ,norm intervention ,Social group ,010104 statistics & probability ,03 medical and health sciences ,0302 clinical medicine ,AcademicSubjects/MED00860 ,Original Research Article ,030212 general & internal medicine ,cultural evolution ,non-WEIRD ,reproductive health ,0101 mathematics ,education ,Ecology, Evolution, Behavior and Systematics ,media_common ,Reproductive health ,norm change ,education.field_of_study ,business.industry ,AcademicSubjects/SCI01130 ,conformity bias ,Evolutionary anthropology ,Outgroup ,Norm (social) ,Psychology ,business ,Social psychology - Abstract
Background and objectives How do new ideas spread in social groups? We apply the framework of cultural evolution theory to examine what drives change in perinatal care norms among Himba women in the Kunene region of Namibia. Access to formal medical care is on the rise in this region, and medical workers regularly visit communities to promote WHO-recommended perinatal care practices. This study investigates how various forms of social transmission affect women’s uptake of medical recommendations concerning perinatal care. Methodology Based on interviews with one hundred Himba mothers, we used Bayesian multi-level logistical regression models to examine how perceptions of group preferences, prestige ascribed to outgroup conformers, interaction with the outgroup and access to resources affect norm adoption. Results Women who perceive medical recommendations as common in their group prefer, plan and practice these recommendations more often themselves. We observed a shift toward medical recommendations regarding birth location and contraception use that was in line with conformity bias predictions. Practices that serve as cultural identity markers persist in the population. Conclusions and implications Norm changes, and the cultural evolutionary processes that can lead to them, are not uniform, either in process or pace. Empirical studies like this one provide important examples of how these changes reflect local culture and circumstance and are critical for better understanding the models that currently predominate in cultural evolution work. These cases can also help bridge the gap between evolutionary anthropology and public health by demonstrating where promotion and prevention campaigns might be most effective. Lay Summary The recent promotion of WHO-recommended perinatal care practices in Namibia provides an opportunity to empirically study norm change using a cultural evolution framework. We found women adopt medical recommendations when they believe these are common in their social group. Local norms that were not discouraged persisted in the study group.
- Published
- 2020
3. Staying alive enhances both women's and men's fitness
- Author
-
Renée V. Hagen, Delaney A. Knorr, Sally Li, Ashley Mensing, and Brooke A. Scelza
- Subjects
Behavioral Neuroscience ,Neuropsychology and Physiological Psychology ,Physiology - Abstract
We argue that Benenson et al. need to consider not only sex differences in the effects of care on offspring survival but also in age-specific fertility when predicting how longevity affects fitness. We review evidence that staying alive has important effects on both women's and men's fitness, and encourage consideration of alternative explanations for observed sex differences in threat responses.
- Published
- 2022
4. Systemtherapie bei Tumoren der Vulva und Vagina
- Author
-
V. Hagen and G. Kunz
- Subjects
0301 basic medicine ,Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,030104 developmental biology ,0302 clinical medicine ,Oncology ,business.industry ,030220 oncology & carcinogenesis ,medicine ,Hematology ,business - Abstract
Mit der zunehmenden Inzidenz der Vulva- und Vaginalkarzinome ist auch mit einer zunehmenden Bedeutung der Systemtherapie bei fortgeschrittenen und metastasierten Tumoren zu rechnen. In den einschlagigen Leitlinien wird der Einsatz bei mangelhafter Datenlage zuruckhaltend bewertet. Die vorliegenden Daten aus der Literatur zur Systemtherapie (ohne Radiochemotherapie) sollen dargestellt werden und auf ihre Anwendbarkeit im Einzelfall in den verschiedenen Therapiesituationen Neoadjuvanz, Adjuvanz und Palliation gewertet werden. Es wurde eine Literaturrecherche in PubMed mit den Schlagwortern „vulvar cancer“ und „systemic therapy“ oder „systemic treatment“ oder „chemotherapy“ oder „neoadjuvant chemotherapy“ sowie „vaginal cancer“ und „systemic treatment“ oder „chemotherapy“ oder „neoadjuvant chemotherapy“ von Januar 1990 bis Juli 2018 durchgefuhrt. Die Daten beschranken sich im Wesentlichen auf retrospektive, einarmige, monozentrische Untersuchungen an meist sehr kleinen Fallzahlen, bestenfalls handelt es sich um prospektive multizentrische Phase-II-Studien. Als Orientierung konnen die bei den haufigeren, biologisch ahnlichen Entitaten Zervixkarzinom und Analkarzinom verwendeten Zytostatika und -kombinationen dienen. Bei jungeren Patientinnen mit HPV(humanes Papillomvirus)-induzierten Vulva- und Vaginalkarzinomen ist mit einer besseren Wirksamkeit und Vertraglichkeit der Chemotherapie zu rechnen. Erste Ergebnisse zu zielgerichteten Therapien deuten auf eine Wirksamkeit von EGFR(„epidermal growth factor receptor“)-gerichteten Therapien. Insbesondere bei HPV-induzierten Tumoren konnte die Krebsimmuntherapie zukunftig eine Option sein. Aufgrund der sparlichen Daten ist ein Einsatz von Systemtherapien auf Einzelfalle zu beschranken, bei denen es um eine Reduzierung von Folgen anderer Therapiemodalitaten gehen muss oder andere Behandlungsoptionen nicht (mehr) zur Verfugung stehen. Die Seltenheit dieser Tumoren macht internationale Studienkooperationen und Registerstudien zur Erfassung der Therapierealitat erforderlich. Eine Chance ist moglicherweise die Ubertragbarkeit von Ergebnissen bei haufigeren Tumorentitaten mit ahnlichen biologischen Eigenschaften und Ansatzen fur zielgerichtete Therapien.
- Published
- 2019
5. Effect of high intake of cod or salmon on serum total neopterin concentration: a randomised clinical trial
- Author
-
Marianne Bratlie, Øivind Midttun, Gunnar Mellgren, Anita Helland, Ingrid V Hagen, Oddrun Anita Gudbrandsen, Per Magne Ueland, and Harald Sveier
- Subjects
0301 basic medicine ,Atlantic salmon ,Antioxidant ,medicine.medical_treatment ,Salmo salar ,Medicine (miscellaneous) ,chemistry.chemical_element ,030204 cardiovascular system & hematology ,Overweight ,Neopterin ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Animal science ,medicine ,Animals ,Humans ,Obesity ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Immune activation ,biology ,business.industry ,Fish intake ,Retinol ,Original Contribution ,medicine.disease ,biology.organism_classification ,Clinical trial ,chemistry ,Seafood ,Atlantic cod ,medicine.symptom ,business ,Selenium - Abstract
Purpose Primarily, to investigate the effect of high intake of cod (lean fish) or salmon (fatty fish) on serum concentration of total neopterin, a marker of cellular immune activation that is associated with cardiovascular disease. Second, to investigate effects of high cod/salmon intake on antioxidant vitamins and elements essential for activity of antioxidant enzymes. Methods In this randomised clinical trial, 63 participants with overweight/obesity consumed 750 g/week of either Atlantic cod (N = 22) or Atlantic salmon (N = 22) or were instructed to continue their normal eating habits but avoid fish intake (Control group, N = 19) for 8 weeks. Food intake was recorded, and fasting serum were collected at baseline and endpoint. Results Serum total neopterin concentration was reduced in the Cod group (median change − 2.65 (25th, 75th percentiles − 3.68, − 0.45) nmol/l, P = 0.018) but not in the Salmon group (median change 0.00 (25th, 75th percentiles − 4.15, 3.05) nmol/l, P = 0.59) when compared with the Control group after 8 weeks. The estimated daily intake of selenium, iron, magnesium and zinc were similar between all groups. Increased serum concentration of selenium was observed only after cod intake when compared to the Control group (P = 0.017). Changes in serum concentrations of copper, iron, magnesium, all-trans retinol, α-tocopherol and γ-tocopherol were similar between the groups. Conclusion A high intake of cod, but not of salmon, lowered serum total neopterin concentration when compared to the Control group. Clinical trial registration This trial was registered at clinicaltrials.gov as NCT02350595
- Published
- 2020
6. Effects of high intake of cod or salmon on gut microbiota profile, faecal output and serum concentrations of lipids and bile acids in overweight adults: a randomised clinical trial
- Author
-
Gunnar Mellgren, Ingrid V Hagen, Grethe Rosenlund, Marianne Bratlie, Friedemann Erchinger, Anita Helland, Trygve Hausken, Øivind Midttun, Per Magne Ueland, Harald Sveier, and Oddrun Anita Gudbrandsen
- Subjects
0301 basic medicine ,Adult ,Firmicutes ,Medicine (miscellaneous) ,Urine ,Gut microbiota ,Gut flora ,Cod ,digestive system ,Bile Acids and Salts ,03 medical and health sciences ,chemistry.chemical_compound ,Feces ,Salmon ,medicine ,Animals ,Humans ,Food science ,Triglycerides ,Faeces ,030109 nutrition & dietetics ,Nutrition and Dietetics ,biology ,Cholesterol ,Clostridiales ,Bacteroidetes ,Original Contribution ,Overweight ,biology.organism_classification ,medicine.disease ,Obesity ,Lipids ,Gastrointestinal Microbiome ,030104 developmental biology ,chemistry - Abstract
PurposeTo explore whether high intake of cod or salmon would affect gut microbiota profile, faecal output and serum concentrations of lipids and bile acids.MethodsSeventy-six adults with overweight/obesity with no reported gastrointestinal disease were randomly assigned to consume 750 g/week of either cod or salmon, or to avoid fish intake (Control group) for 8 weeks. Fifteen participants from each group were randomly selected for 72 h faeces collection at baseline and end point for gut microbiota profile analyses using 54 bacterial DNA probes. Food intake was registered, and fasting serum and morning urine were collected at baseline and end point.ResultsSixty-five participants were included in serum and urine analyses, and gut microbiota profile was analysed for 33 participants. Principal component analysis of gut microbiota showed an almost complete separation of the Salmon group from the Control group, with lower counts for bacteria in theBacteroidetesphylum and theClostridialesorder of theFirmicutesphyla, and higher counts for bacteria in theSelenomonadalesorder of theFirmicutesphylum. The Cod group showed greater similarity to the Salmon group than to the Control group. Intake of fibres, proteins, fats and carbohydrates, faecal daily mass and output of fat, cholesterol and total bile acids, and serum concentrations of cholesterol, triacylglycerols, non-esterified fatty acids and total bile acids were not altered in the experimental groups.ConclusionA high intake of cod or salmon fillet modulated gut microbiota but did not affect faecal output or serum concentrations of lipids and total bile acids.Clinical trial registrationThis trial was registered at clinicaltrials.gov as NCT02350595.
- Published
- 2020
7. High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n-3 PUFA content in the leucocyte membrane in healthy overweight adults: a randomised trial
- Author
-
Anita Helland, Svein A. Mjøs, Gunnar Mellgren, Harald Sveier, Ingrid V Hagen, Steinar Sørnes, Oddrun Anita Gudbrandsen, Grethe Rosenlund, Alfred Halstensen, Marianne Bratlie, and Karl A. Brokstad
- Subjects
Adult ,Blood Glucose ,Male ,0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,Medicine (miscellaneous) ,030209 endocrinology & metabolism ,Type 2 diabetes ,Overweight ,Biology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Fatty Acids, Omega-3 ,Leukocytes ,medicine ,Animals ,Humans ,education ,Inflammation ,chemistry.chemical_classification ,education.field_of_study ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Insulin ,C-reactive protein ,Fishes ,Middle Aged ,medicine.disease ,Dietary Fats ,Endocrinology ,Postprandial ,chemistry ,Hyperglycemia ,biology.protein ,Female ,Blood sugar regulation ,medicine.symptom ,Biomarkers ,Food Analysis ,Polyunsaturated fatty acid - Abstract
The prevalence of type 2 diabetes (T2D) is low in populations with a high fish intake; however prospective studies with fish intake have shown positive, negative or no association between fish intake and the risk for T2D. The aim of this study was to investigate the effects of high intake of lean or fatty fish on glucose tolerance, leucocyte membrane fatty acid composition and leucocyte function in overweight/obese adults. In this randomised clinical trial, sixty-eight healthy overweight/obese participants consumed 750 g/week of either lean or fatty fish as dinners, or were instructed to continue their normal eating habits but to avoid fish intake (control group), for 8 weeks. Energy and macronutrient intake and physical activity were not changed within the groups during the study period. High intake of fatty fish, but not of lean fish, significantly improved glucose regulation 120 min postprandially (P=0·012), but did not affect fasting glucose concentration. A smaller increase in fasting to 120 min postprandial insulin C-peptide concentration was seen after fatty fish intake (P=0·012). Lean fish increased the DHA content in leucocyte membranes (P=0·010), and fatty fish increased the total content of n-3 PUFA (P=0·00016) and reduced the content of n-6 PUFA (P=0·00057) in leucocyte membranes. Lean and fatty fish intake did not affect phagocytosis of bacteria ex vivo. The findings suggest that high intake of fatty fish, but not of lean fish, beneficially affected postprandial glucose regulation in overweight/obese adults, and may therefore prevent or delay the development of T2D in this population.
- Published
- 2017
8. Five salmon dinners per week were not sufficient to prevent the reduction in serum vitamin D in autumn at 60° north latitude: a randomised trial
- Author
-
Gunnar Mellgren, Ingrid V Hagen, Arve Ulvik, Per Magne Ueland, Øivind Midttun, Harald Sveier, Anita Helland, Marianne Bratlie, Grethe Rosenlund, and Oddrun Anita Gudbrandsen
- Subjects
0301 basic medicine ,Adult ,Male ,Adolescent ,Medicine (miscellaneous) ,Nutritional Status ,Type 2 diabetes ,030204 cardiovascular system & hematology ,Overweight ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Animal science ,Insulin resistance ,Salmon ,Vitamin D and neurology ,medicine ,Animals ,Humans ,Meals ,Calcifediol ,Serum vitamin ,030109 nutrition & dietetics ,Nutrition and Dietetics ,Geography ,business.industry ,Norway ,Feeding Behavior ,Middle Aged ,medicine.disease ,Vitamin D Deficiency ,Obesity ,Diet ,Increased risk ,Seafood ,Normal eating habits ,Female ,Seasons ,medicine.symptom ,business - Abstract
Low serum concentrations of several vitamins have been linked to increased risk of diseases including insulin resistance and type 2 diabetes (T2D). Fish is a good source of several vitamins, and the prevalence of T2D is low in populations with high fish intake. The aim of the present study was to investigate the effects of high fish intake on vitamins in serum from adults in autumn in South-Western Norway at 60° north latitude. In this randomised clinical trial, sixty-three healthy participants with overweight/obesity consumed 750 g/week of either cod (n22) or salmon (n22) as five weekly dinners or were instructed to continue their normal eating habits but avoid fish intake (Control group,n19) for 8 weeks. The estimated vitamin D intake was significantly increased in the Salmon group when compared with the Cod group (P= 6·3 × 10−4) and with the Control group (P= 3·5 × 10−6), with no differences between groups for estimated intake of vitamins A, B1, B2, B3, B6, B9, C and E. Serum 25-hydroxyvitamin D3concentration was decreased in all groups after 8 weeks; however, the reduction in the Salmon group was significantly smaller compared with the Cod group (P= 0·013) and the Control group (P= 0·0060). Cod and salmon intake did not affect serum concentrations of the other measured vitamins. The findings suggest that 750 g/week of salmon was not sufficient to prevent a decrease in serum 25-hydroxyvitamin D3in autumn in South-Western Norway in adults with overweight/obesity.
- Published
- 2019
9. Intact and Isolated Human Cadaveric Coronary Artery Perfusion Models to Facilitate Research and Education Regarding Coronary Anatomy and Pathology
- Author
-
John L, Petersen, Dmitry B, Levin, Vivian W, Hou, Carol V, Hagen, Grant, Anderson, Joanie, Block, and Mark, Reisman
- Subjects
Perfusion ,Education, Medical, Graduate ,Coronary Circulation ,Fluoroscopy ,Cadaver ,Cardiology ,Humans ,Coronary Artery Disease ,Coronary Vessels - Abstract
Cadaveric tissue-perfusion models are well established in the fields of structural heart and peripheral vascular disease; however, less consideration has been given toward coronary artery disease despite comparable prevalence and morbidity. Two tissue-perfusion models were developed to address this need. The first, an intact heart model, allows simulation of percutaneous coronary interventional procedures. The second focuses upon isolated arteries, allowing quantification of simulated procedures. Both models were applied for clinical training and for investigations into medical device behavior. The manner of preparation facilitates access to clinically relevant disease, thus providing a platform to further research on coronary artery disease.
- Published
- 2019
10. TMAO, creatine and 1-methylhistidine in serum and urine are potential biomarkers of cod and salmon intake: a randomised clinical trial in adults with overweight or obesity
- Author
-
Per Magne Ueland, Harald Sveier, Øivind Midttun, Gunnar Mellgren, Marianne Bratlie, Adrian McCann, Oddrun Anita Gudbrandsen, Grethe Rosenlund, Ingrid V Hagen, and Anita Helland
- Subjects
0301 basic medicine ,Adult ,Medicine (miscellaneous) ,Physiology ,030209 endocrinology & metabolism ,Urine ,Overweight ,Creatine ,03 medical and health sciences ,chemistry.chemical_compound ,Methylamines ,0302 clinical medicine ,Salmon ,medicine ,Animals ,Humans ,Obesity ,1-Methylhistidine ,Creatinine ,030109 nutrition & dietetics ,Nutrition and Dietetics ,business.industry ,medicine.disease ,Methylhistidines ,Clinical trial ,chemistry ,Potential biomarkers ,medicine.symptom ,business ,Biomarkers - Abstract
To identify biomarkers to assess participants’ compliance in an intervention study with high intake of cod or salmon, compared to a fish-free diet. In this randomised clinical trial, 62 healthy overweight/obese participants consumed 750 g/week of either cod (N = 21) or salmon (N = 22) across 5 weekly dinners, or were instructed to continue their normal eating habits but avoid fish intake (Control group, N = 19) for 8 weeks. After cod intake, serum concentrations of trimethylamine N-oxide (TMAO, p = 0.0043), creatine (p = 0.024) and 1-methylhistidine (1-MeHis, p = 0.014), and urine concentrations (relative to creatinine) of TMAO (p = 2.8 × 10−5), creatine (p = 8.3 × 10−4) and 1-MeHis (p = 0.016) were increased when compared to Control group. After salmon intake, serum concentrations of 1-MeHis (p = 2.0 × 10−6) and creatine (p = 6.1 × 10−4), and urine concentrations (relative to creatinine) of 1-MeHis (p = 4.2 × 10−6) and creatine (p = 4.0 × 10−5) were increased when compared to Control group. Serum and urine concentrations of TMAO were more increased following cod intake compared to salmon intake (p = 0.028 and 2.9 × 10−4, respectively), and serum and urine 1-MeHis concentrations were more increased after salmon intake compared to cod intake (p = 8.7 × 10−5 and 1.2 × 10−4, respectively). Cod and salmon intake did not affect serum and urine concentrations of 3-methylhistidine, and only marginally affected concentrations of free amino acids and amino acid metabolites. TMAO measured in serum or urine is a potential biomarker of cod intake, and 1-MeHis measured in serum or urine is a potential biomarker of salmon intake.
- Published
- 2019
11. High intake of fatty fish, but not of lean fish, affects serum concentrations of TAG and HDL-cholesterol in healthy, normal-weight adults: a randomised trial
- Author
-
Gunnar Mellgren, Marianne Bratlie, Ingrid V Hagen, Karl A. Brokstad, Grethe Rosenlund, Anita Helland, Harald Sveier, and Oddrun Anita Gudbrandsen
- Subjects
Adult ,Male ,0301 basic medicine ,Medicine (miscellaneous) ,Type 2 diabetes ,Poultry ,Eating ,Young Adult ,03 medical and health sciences ,Fatty fish ,chemistry.chemical_compound ,Animal science ,Risk Factors ,Salmon ,medicine ,Animals ,Humans ,Triglycerides ,030109 nutrition & dietetics ,Nutrition and Dietetics ,biology ,Cholesterol ,business.industry ,Cholesterol, HDL ,C-reactive protein ,nutritional and metabolic diseases ,Fasting ,Serum concentration ,Postprandial Period ,medicine.disease ,Dietary Fats ,Healthy Volunteers ,Diet ,Postprandial ,Diabetes Mellitus, Type 2 ,Gadus morhua ,Seafood ,chemistry ,Cardiovascular Diseases ,biology.protein ,%22">Fish ,Female ,Blood sugar regulation ,business ,Chickens - Abstract
The aim of the present study was to examine whether high intake of lean or fatty fish (cod and farmed salmon, respectively) by healthy, normal-weight adults would affect risk factors of type 2 diabetes and CVD when compared with lean meat (chicken). More knowledge is needed concerning the potential health effects of high fish intake (>300 g/week) in normal-weight adults. In this randomised clinical trial, thirty-eight young, healthy, normal-weight participants consumed 750 g/week of lean or fatty fish or lean meat (as control) for 4 weeks at dinner according to provided recipes to ensure similar ways of preparations and choices of side dishes between the groups. Energy and macronutrient intakes at baseline and end point were similar in all groups, and there were no changes in energy and macronutrient intakes within any of the groups during the course of the study. High intake of fatty fish, but not lean fish, significantly reduced TAG and increased HDL-cholesterol concentrations in fasting serum when compared with lean meat intake. When compared with lean fish intake, fatty fish intake increased serum HDL-cholesterol. No differences were observed between lean fish, fatty fish and lean meat groups regarding fasting and postprandial glucose regulation. These findings suggest that high intake of fatty fish, but not of lean fish, could beneficially affect serum concentrations of TAG and HDL-cholesterol, which are CVD risk factors, in healthy, normal-weight adults, when compared with high intake of lean meat.
- Published
- 2016
12. MECHANISM OF ACTION OF ORBITAL ATHERECTOMY IN SEVERELY CALCIFIED CORONARY ARTERIES: INSIGHTS FROM A CADAVERIC PERFUSION MODEL
- Author
-
Florencia G. Jalikis, Carol V. Hagen, Vivian W. Hou, John Petersen, Haodong Xu, and Dmitry Levin
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Stent ,Orbital atherectomy ,Coronary arteries ,medicine.anatomical_structure ,Mechanism of action ,Heart perfusion ,Internal medicine ,medicine ,Cardiology ,In patient ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Cadaveric spasm ,Perfusion - Abstract
Orbital atherectomy (OA) is indicated for facilitating stent delivery in patients by reducing coronary plaque, but complete understanding of the therapeutic mechanism has not been established. We performed a mechanistic study using a cadaveric heart perfusion model to investigate the impact of OA on
- Published
- 2019
13. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
- Author
-
S. Ramalingam, J. Crawford, A. Chang, C. Manegold, R. Perez-Soler, J.-Y. Douillard, N. Thatcher, F. Barlesi, T. Owonikoko, Y. Wang, P. Pultar, J. Zhu, R. Malik, G. Giaccone, S. Della-Fiorentina, S. Begbie, R. Jennens, J. Dass, K. Pittman, N. Ivanova, T. Koynova, P. Petrov, A. Tomova, V. Tzekova, F. Couture, V. Hirsh, R. Burkes, R. Sangha, M. Ambrus, T. Janaskova, J. Musil, J. Novotny, P. Zatloukal, J. Jakesova, K. Klenha, J. Roubec, J. Vanasek, J. Fayette, J. Bennouna-Louridi, C. Chouaid, J. Mazières, H. Vallerand, G. Robinet, P.-J. Souquet, D. Spaeth, R. Schott, H. Lena, Y. Martinet, C. El Kouri, N. Baize, A. Scherpereel, O. Molinier, F. Fuchs, K.M. Josten, N. Marschner, F. Schneller, T. Overbeck, M. Thomas, J. von Pawel, M. Reck, W. Schuette, V. Hagen, C.-P. Schneider, V. Georgoulias, I. Varthalitis, K. Zarogoulidis, K. Syrigos, C. Papandreou, C. Bocskei, E. Csanky, E. Juhasz, G. Losonczy, Z. Mark, I. Molnar, Z. Papai-Szekely, S. Tehenes, I. Vinkler, S. Almel, A. Bakshi, S. Bondarde, A. Maru, A. Pathak, R.M. Pedapenki, K. Prasad, S.V.S.S. Prasad, N. Kilara, D. Gorijavolu, C.D. Deshmukh, S. John, L.M. Sharma, D. Amoroso, E. Bajetta, P. Bidoli, A. Bonetti, F. De Marinis, M. Maio, R. Passalacqua, S. Cascinu, A. Bearz, M. Bitina, A. Brize, G. Purkalne, M. Skrodele, A.A. Baba, K. Ratnavelu, M.H. Saw, M.C. Samson-Fernando, G.E. Ladrera, J. Jassem, P. Koralewski, P. Serwatowski, M. Krzakowski, C. Cebotaru, D. Filip, D.E. Ganea-Motan, C.H. Ianuli, I.G. Manolescu, A. Udrea, O. Burdaeva, M. Byakhov, A. Filippov, S. Lazarev, I. Mosin, S. Orlov, D. Udovitsa, A. Khorinko, S. Protsenko, H.L. Lim, Y.O. Tan, E.H. Tan, R. Bastus Piulats, J. Garcia-Foncillas, J. Valdivia, J. de Castro, M. Domine Gomez, S.W. Kim, J.-S. Lee, H.K. Kim, J.S. Lee, S.W. Shin, D.-W. Kim, Y.-C. Kim, K.C. Park, C.-S. Chang, G.-C. Chang, Y.-G. Goan, W.-C. Su, C.-M. Tsai, H.-P. Kuo, M. Benekli, G. Demir, E. Gokmen, A. Sevinc, M. Haigentz, M. Agarwal, S. Pandit, R. Araujo, N. Vrindavanam, P. Bonomi, A. Berg, J. Wade, R. Bloom, B. Amin, R. Camidge, D. Hill, M. Rarick, P. Flynn, L. Klein, K. Lo Russo, M. Neubauer, P. Richards, R. Ruxer, M. Savin, D. Weckstein, R. Rosenberg, T. Whittaker, D. Richards, W. Berry, C. Ottensmeier, A. Dangoor, N. Steele, Y. Summers, E. Rankin, K. Rowley, S. Giridharan, H. Kristeleit, C. Humber, P. Taylor, Ramalingam, S, Crawford, J, Chang, A, Manegold, C, Perez-Soler, R, Douillard, J, Thatcher, N, Barlesi, F, Owonikoko, T, Wang, Y, Pultar, P, Zhu, J, Malik, R, Giaccone, G, and Bidoli, P
- Subjects
Male ,medicine.medical_specialty ,Population ,Kaplan-Meier Estimate ,Placebo ,Gastroenterology ,Disease-Free Survival ,Drug Administration Schedule ,Placebos ,Double-Blind Method ,Talactoferrin Alfa ,Carcinoma, Non-Small-Cell Lung ,Internal medicine ,Talactoferrin ,Humans ,Medicine ,Phase III study ,Progression-free survival ,education ,Lung cancer ,Survival rate ,Aged ,Neoplasm Staging ,education.field_of_study ,business.industry ,Surrogate endpoint ,Hazard ratio ,Hematology ,Middle Aged ,medicine.disease ,Surgery ,oral dendritic cell (DC)-mediated immunotherapy ,Lactoferrin ,Treatment Outcome ,Oncology ,Female ,Immunotherapy ,Immunotherapy, Non-small-cell lung cancer, Phase III study, Talactoferrin ,business ,Non-small-cell lung cancer - Abstract
Background Talactoferrin alfa is an oral dendritic cell (DC)-mediated immunotherapy (DCMI). We tested whether talactoferrin was superior to placebo in advanced non-small-cell lung cancer (NSCLC). Patients and methods An FORTIS-M trial was an international, multicenter, randomized, double-blind comparison of talactoferrin (1.5g p.o. BID) versus placebo BID, in patients with stage IIIB/IV NSCLC whose disease had failed two or more prior regimens. Treatment was administered for a maximum of five 14-week cycles. The primary efficacy end point was overall survival (OS); secondary end points included 6- and 12-month survival, progression-free survival (PFS), and disease control rate (DCR). Results Seven hundred and forty-two patients were randomly assigned (2:1) to talactoferrin (497) or placebo (245). The median OS in the intent-to-treat (ITT) population was 7.66 months in the placebo arm and 7.49 months in the talactoferrin arm [hazard ratio (HR), 1.04; 95% CI, 0.873–1.24; P = 0.6602]. The 6-month survival rates were 59.9% (95% CI, 53.4% to 65.8%) and 55.7% (95% CI, 51.1% to 59.9%), respectively. The 12-month survival rates were 32.2% (95% CI, 26.3% to 38.2%) and 30.9% (95% CI, 26.8% to 35%), respectively. The median PFS rates were 1.64 months and 1.68 months, respectively (HR, 0.99; 95% CI, 0.835–1.16; P = 0.8073). The DCRs were 38.4 and 37.6%, respectively [stratified odds ratio (OR), 0.96; 95% CI, 0.698–1.33; P = 0.8336]. The safety profiles were comparable between arms. Conclusions There was no improvement in efficacy with talactoferrin alfa in patients with advanced NSCLC whose disease had failed two or more previous regimens.
- Published
- 2013
14. Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study
- Author
-
P V, Hagen, M V, Heijl, M I V B, Henegouwen, R, Boellaard, P M M, Bossuyt, F J W T, Kate, H V, Dekken, O S, Hoekstra, G W, Sloof, and J J B V, Lanschot
- Subjects
Adult ,Male ,Esophageal Neoplasms ,Chemoradiotherapy, Adjuvant ,Middle Aged ,Disease-Free Survival ,Neoadjuvant Therapy ,Treatment Outcome ,Fluorodeoxyglucose F18 ,Predictive Value of Tests ,Positron-Emission Tomography ,Multivariate Analysis ,Disease Progression ,Humans ,Female ,Prospective Studies ,Radiopharmaceuticals ,Aged ,Follow-Up Studies - Abstract
18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) has been investigated as a tool for monitoring response to neoadjuvant chemo- and chemoradiotherapy (CT and CRT, respectively) and as a predictor for survival in patients with esophageal cancer. In contrast to patients who undergo neoadjuvant CT, it is not known whether patients who are clinically identified as responders after neoadjuvant CRT show better disease-free survival (DFS) than patients identified as nonresponders. The aim of the study was to determine the predictive value of FDG-uptake measured prior to and early during neoadjuvant CRT. Patients treated with neoadjuvant CRT between 2004 and 2009 within a randomized trial were included. FDG-uptake was measured at baseline and after 14 days of CRT. According to the PERCIST-criteria, patients were allocated to have metabolic response, stable disease, or progression. Patients were followed until recurrence of disease or death. The predictive value of FDG-PET was determined with univariable and multivariable analysis in patients who underwent potentially curative surgery. One-hundred and six patients were included in the analysis. Minimal follow-up for surviving patients was 60 months. No significant differences in DFS were found between patients with metabolic response, stable disease, or progression, with 5-year DFS rates of 66%, 53%, and 67%, respectively (P = 0.39). Relative change in FDG uptake after 14 days of CRT is not associated with DFS in patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy followed by surgery. These measurements should not be used for prognostication in this specific group of patients.
- Published
- 2016
15. First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial
- Author
-
M, Kaufmann, N, Maass, S D, Costa, A, Schneeweiss, S, Loibl, M W, Sütterlin, I, Schrader, B, Gerber, W, Bauer, W, Wiest, O, Tomé, A, Distelrath, V, Hagen, A, Kleine-Tebbe, E, Ruckhaeberle, K, Mehta, G, von Minckwitz, and C, Karg
- Subjects
Adult ,Male ,Antimetabolites, Antineoplastic ,Cancer Research ,medicine.medical_specialty ,Nausea ,medicine.medical_treatment ,Breast Neoplasms ,Deoxycytidine ,Gastroenterology ,Disease-Free Survival ,Breast Neoplasms, Male ,Metastasis ,Capecitabine ,Breast cancer ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Neoplasm Metastasis ,Aged ,Aged, 80 and over ,Chemotherapy ,business.industry ,Cancer ,Middle Aged ,medicine.disease ,Metastatic breast cancer ,Surgery ,Oncology ,Disease Progression ,Quality of Life ,Female ,Fluorouracil ,Breast disease ,medicine.symptom ,business ,medicine.drug - Abstract
To determine activity and safety of capecitabine at a moderate dose of 2000 mg/m(2) as first-line therapy for metastatic breast cancer.In this prospective phase II trial, patients with HER2-negative metastatic breast cancer received first-line capecitabine 2000 mg/m(2) on days 1-14 every 3 weeks. The primary aim was to exclude a time to progression (TTP)6 months. Secondary end-points were overall response rate, overall survival (OS), toxicity and quality of life.Median age of the 161 included patients was 65 years. Median TTP and OS were 7.3 months [95% (confidence interval) CI: 6.2-8.4] and 17.1 months (95% CI: 14.0-20.3), respectively. An overall response rate of 26.1%, including 13 complete remissions was observed. Patients developing grade I-III hand-foot syndrome had a significantly longer TTP and OS and patients65 years also achieved a significantly longer TTP. Haematological grade I-IV toxicities were leucopenia (64.0%), anaemia (50.9%) and thrombocytopenia (28.0%). Relevant non-haematological toxicities were hand-food-syndrome (37.3%), fatigue (34.2%), nausea (29.8%) and diarrhoea (20.5%). Quality of life assessment revealed an improved emotional function, but worsening of nausea and vomiting from cycle 1-10.Capecitabine at a dose of 2000 mg/m(2) is active and safe as first-line treatment of patients with metastatic breast cancer.
- Published
- 2010
16. Katalysatorcharakterisierung mit O2-TPD, N2- und Kr-Gassorption sowie REM am Beispiel der Epoxidierung von 1,3-Butadien. Catalyst Characterization with O2-TPD, N2 -,Kr-sorption and SEM Using the Example of the Epoxidation of 1,3-Butadiene
- Author
-
A. Puls, E. Dinjus, V. Hagen, and T. N. Otto
- Subjects
Chemistry ,General Chemical Engineering ,Polymer chemistry ,General Chemistry ,Reaction system ,Industrial and Manufacturing Engineering ,Analysis method - Abstract
Die temperaturprogrammierte O2-Desorption (O2-TPD), die N2- und Kr- Gassorption sowie die Raster-Elektronen-Mikroskopie (REM) sind bedeutende Analysemethoden in der Katalysechemie. Am Beispiel eines korund- und eines calciumhexaaluminathaltigen Tragermaterials werden die Methoden angewendet und das Potenzial der eingesetzten Katalysatoren hinsichtlich der Oberflacheneigenschaften und der damit verbundenen Aktivitat aufgezeigt. Welches der beiden getragerten Katalysatorsysteme fur die Ag-katalysierte Epoxidierung von 1,3-Butadien zu 3,4-Epoxy-1-buten vorteilhafter ist, wird im Rohrreaktor getestet. The temperature-programmed O2 desorption (O2-TPD), the N2- and Kr- sorption as well as the scanning-electron microscope (SEM) are important analysis methods in catalysis chemistry. By the example of a corundum and of a calcium hexaaluminate substrate the methods are used and the potential regarding to the surface properties and the activity of the assigned catalysts thereby pointed. Which of the two catalyst systems for the Ag-catalyzed epoxidation of 1,3-butadiene to 3,4-epoxy-1-butene is more favorable is tested in a tubular reactor.
- Published
- 2010
17. Stärlinge und Kärpflinge als Eiräuber bei der Winkerkrabbe Uca vocator (Herbst)
- Author
-
Heinrich‐Otto v. Hagen
- Subjects
General Earth and Planetary Sciences ,Animal Science and Zoology ,Biology ,Ecology, Evolution, Behavior and Systematics ,General Environmental Science - Published
- 2010
18. HIGH-RESOLUTION ANGIOSCOPY OF PROXIMAL CHRONIC TOTAL OCCLUSION MICROCHANNELS USING THE SCANNING FIBER ENDOSCOPE
- Author
-
John W. Petersen, Dmitry Levin, William Lombardi, Carol V. Hagen, Vivian W. Hou, and Eric J. Seibel
- Subjects
Endoscope ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Percutaneous coronary intervention ,High resolution ,Angioscopy ,01 natural sciences ,Total occlusion ,010309 optics ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,0103 physical sciences ,medicine ,Fiber ,Cardiology and Cardiovascular Medicine ,business ,Biomedical engineering - Abstract
Prior anatomic studies demonstrate frequent existence of patent microchannels in Chronic Total Occlusions (CTOs) but real-time visualization to guide Percutaneous Coronary Intervention is limited. The Scanning Fiber Endoscope (SFE) is a novel technology that provides images with significantly
- Published
- 2018
19. Impfstrategien bei Schwerem Akutem Respiratorischem Syndrom (SARS)
- Author
-
P. Zabel, Mathias W. Pletz, Torsten T. Bauer, Nicolas Dickgreber, Tobias Welte, L. V. Hagen, David A. Groneberg, and Heiko Golpon
- Subjects
Pulmonary and Respiratory Medicine ,Exacerbation ,biology ,business.industry ,fungi ,Disease ,medicine.disease ,Virology ,Viral vector ,body regions ,Vaccination ,Immunization ,Immunology ,biology.protein ,Medicine ,Severe acute respiratory syndrome ,Antibody ,skin and connective tissue diseases ,business ,Viral load - Abstract
Most patients with severe acute respiratory syndrome (SARS) develop antibodies against the SARS coronavirus and survive the infection. This suggests that active or passive immunisation might be an effective option in preventing or treating SARS. Therefore, the development of SARS vaccination strategies belongs to the most important targets of SARS research. The present study analyses data-bases for the current knowledge on vaccination strategies. Both, passive and active immunisation protocols are presently being developed. Passive immunisation with sera from surviving patients leads to partial success. Whereas the passive immunisation exhibits a promising therapeutic tool, only active immunisation can successfully prevent infection. A number of approaches has been used on the basis of inactivated SARS coronaviruses, recombinant subunits, recombinant DNA, and viral vectors. However, all recently developed candidates need to be evaluated critically before clinical use. The so-called "antibody-dependent enhancement" can improve viral uptake into host cells resulting in increased viral load and exacerbation of disease.
- Published
- 2007
20. Optical and infrared monitoring of BL Lac in 1999–2001
- Author
-
Valeri M. Larionov, Vladimir A. Hagen-Thorn, Elena G. Larionova, Nadia Kudryavtseva, Anton V. Tikhonov, A. Di Paola, Francesco D'Alessio, A. V. Hagen-Thorn, and A. A. Arkharov
- Subjects
Physics ,Space and Planetary Science ,Infrared ,law ,Spectral energy distribution ,Astronomy and Astrophysics ,Astrophysics ,Synchrotron ,law.invention - Abstract
We present the results of our multicolor observations of BL Lac in the period 1999–2001. We show that the spectral energy distribution of the variable component in the range from K to B had remained unchanged for three years. The power-law spectrum is indicative of its synchrotron nature.
- Published
- 2004
21. Surface morphology of MgO (100) crystals implanted with MeV Al+ and Al2+ ions
- Author
-
Roland Wiesendanger, G. Kuri, Gerhard Materlik, and V. Hagen
- Subjects
Crystal ,Crystallography ,Materials science ,Ion implantation ,Analytical chemistry ,General Materials Science ,General Chemistry ,Substrate (electronics) ,Irradiation ,Thermal treatment ,Crystallographic defect ,Fluence ,Ion - Abstract
MgO (100) single crystals are implanted with 1.50-MeV Al+ and 3.00-MeV Al2 + ions at a fluence of 1×1015 Al atoms cm-2 under high-vacuum conditions. The surface morphology of the substrate is measured in air using atomic force microscopy and X-ray reflectometry followed by computer-simulated spectrum analysis. The ion-irradiated areas are found to protrude to different heights on the nanometre scale. Small height differences are observed in the areas irradiated by Al+ and Al2 + ions of comparable energy, dose rate and total fluence. The results indicate that protrusions are most likely caused by implantation-induced point defects (vacancies) generated in the crystal during implantation. Other possibilities for the cause of protrusions are discussed. Thermal treatment stimulates a partial recovery of the implantation damage and alters the topography of MgO surfaces.
- Published
- 2001
22. [Untitled]
- Author
-
Svetlana G. Jorstad, P. Boltwood, Vladimir A. Hagen-Thorn, T. Pursimo, L. O. Takalo, A. Sillanpää, and A. V. Hagen-Thorn
- Subjects
Physics ,Variable source ,Energy distribution ,law ,Astronomy ,Astronomy and Astrophysics ,Astrophysics ,Blazar ,Power law ,Synchrotron ,law.invention - Abstract
The results of multicolor observations of the blazar 3C 66A, obtained in the course of the project OJ-94, are analyzed. It is established that the energy distribution of the variable source in the optical and IR ranges can be represented, on the average, by a power law: Fν ∝ ν-0.92. Since the blazar's emission is strongly polarized, there is no doubt of the synchrotron nature of the variable source responsible for the blazar's activity.
- Published
- 2001
23. Analysis of the color variability of BL Lac in the visible range during the 1997 outburst
- Author
-
A. V. Hagen-Thorn, Vladimir A. Hagen-Thorn, O. V. Mikolaichuk, and S. G. Marchenko
- Subjects
Physics ,Variable source ,Energy distribution ,law ,Astrophysics::High Energy Astrophysical Phenomena ,Visible range ,Astrophysics::Solar and Stellar Astrophysics ,Astronomy and Astrophysics ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics ,Synchrotron ,law.invention - Abstract
The color variability of BL Lac during the strong 1997 outburst was studied. It was found that the energy distribution in the spectrum of the variable source, which determines the object’s photometric behavior, did not vary during the outburst. It was a power- law spectrum and was flatter than during other, lower-power out-bursts. There is no doubt of the synchrotron nature of the variable source.
- Published
- 2000
24. Coupling of electromagnetic energy to a scatterer inside a cavity: A combined statistical and integral representation approach
- Author
-
J. V. Hagen, W. Tabbara, D. Lecointe, and J. Lefebvre
- Subjects
Aperture ,Mathematical analysis ,Plane wave ,Geometry ,Electric-field integral equation ,Optical field ,Condensed Matter Physics ,Electromagnetic radiation ,Integral equation ,General Earth and Planetary Sciences ,Electrical and Electronic Engineering ,Magnetic dipole ,Voltage ,Mathematics - Abstract
We consider an electromagnetic compatibility problem, where an electromagnetic plane wave, incident on an aperture in the wall of a cavity, is coupled to a set of enclosed metallic plates and a monopole is connected to the base of the cavity and loaded with an impedance. For an aperture of moderate dimensions, one can define an equivalent problem where the incident wave is the one radiated by electric and magnetic dipoles placed inside the cavity with the aperture short-circuited. To predict the voltage induced on the load, an integral representation of the electric field combined with the Green's function of the cavity is used to model the electric field. This reduces the set of unknowns to the values of the currents on the monopole and on the plates. A method of moments is then used to solve the related integral equation. The analysis of the variations of the average and maximum values of the voltage over a given frequency band, as a function of the parameters of the structure, is conducted in an unusual manner. We use statistical tools such as experiment design, regression, and kriging to determine the prevailing parameters and their degree of correlation and to provide a fast prediction of the average and maximum values of the voltage.
- Published
- 2000
25. Polarization-selective surfaces composed of trefoil knot elements
- Author
-
J. v. Hagen, Douglas H. Werner, and Raj Mittra
- Subjects
Physics ,business.industry ,Forward scatter ,Condensed Matter Physics ,Polarization (waves) ,Mathematics::Geometric Topology ,Molecular physics ,Atomic and Molecular Physics, and Optics ,Selective surface ,Electronic, Optical and Magnetic Materials ,Optics ,Knot (unit) ,Electrical and Electronic Engineering ,business ,Microwave ,Trefoil knot - Abstract
In this paper, we demonstrate that the trefoil knot has the unique property that its forward scattering for circularly polarized wa es exhibits a strong dependence on the handedness of the polarization. Both a single knot element as well as an array of these knots show this ( ) property which could be used in a polarization-selecti e surface PSS . Q 1999 John Wiley & Sons, Inc. Microwave Opt Technol Lett 21: 170]173, 1999.
- Published
- 1999
26. Variable Sources in Active Galactic Nuclei
- Author
-
A. V. Hagen-Thorn, Vladimir A. Hagen-Thorn, S. G. Marchenko, and V. A. Yakovleva
- Subjects
Physics ,Variable (computer science) ,Active galactic nucleus ,Astronomy ,Astrophysics - Abstract
The problem of the activity of extragalactic objects is one of the main problems of current astrophysics. There are many manifestations of activity but the photometric and polarimetric variability in IR, optical, UV and X-ray regions is probably one of the most important. The sources responsible for the variability are placed in the nearest neighbourhood of a central engine. Clarifying the nature of these sources might give a tool to the solution of the problem of nuclear activity in general.
- Published
- 1999
27. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation
- Author
-
Karen Williams, Carolyn Peterson, S. Narayan, Margaret F. Turk, Julie H. Carter, C. Schell, Carlos Singer, Chad W. Christine, Paul J. Tuite, Robyn Schacherer, J. Whetteckey, S. Phipps, Diane K. Marek, William C. Nichols, John M. Bertoni, A. H. Rajput, Kenneth Marek, An Tran, P. Ryan, J. Hevezi, Joan Werner, Kelvin L. Chou, S. Chouinard, James Sutton, Margaret C. Lannon, T. Ajax, Joan Young, Deborah Judd, L. Zelaya, David Grimes, Magali Fernandez, Theresa A. Zesiewicz, Mark Stacy, Peggy Gray, Debra Berry, Michael J. Aminoff, C. Horn, C. Costan-Toth, J. Mannetter, Patricia Simpson, Susan Rolandelli, Tatiana Foroud, T. Tra, S. Wilson, Judith Dobson, Nestor Galvez-Jimenez, Donna Schwieterman, Shirley Uy, K. Price, J. Wojcieszek, Anette Nieves, Paul Atchison, Susan Bennett, L. Klassen, A. Podichetty, Vincent Calabrese, Becky Dunlop, D. Kamp, Holly Delgado, Sandra Roque, Maureen A. Leehey, Richard Camicioli, Julie So, Jayaraman Rao, Kelly E. Lyons, Kapil D. Sethi, A. Wang, Lynn Marlor, David Oakes, S. Culver, Juan Sanchez-Ramos, L. Woodward, J. Danielson, Jeannine Petit, Joann Belden, E. Licari, M. Meacham, Deborah Fontaine, Sharon Evans, C. Stone, S. Morehouse, Christopher F. O'Brien, G. Podskalny, J. Fraser, Anthony E. Lang, W.R. Wayne Martin, Carmen Serrano, H. Poiffaut, Stewart A. Factor, Joanne Wojcieszek, S. Belber, L. Davis, C. Allen, J. Hall, Judy Richman, Joseph Jankovic, Carson Reider, Stephen G. Reich, Stephanie Thomas, Kathy Davis, Richard B. Dewey, Karen Marder, T. Demarcaida, A. Kaczmarek, Lauren Seeberger, C. Halter, Mary Lou Klimek, Donald S. Higgins, Miodrag Velickovic, Joanna Hamann, Eric Siemers, E. Ohmann, C. Dingmann, Galit Kleiner-Fisman, Shari Niswonger, Theresa Derian, Maryan DeAngelis, Aileen Shinaman, Tilak Mendis, M. Rundle, Susan Mendick, L. Giffin, Karen Blindauer, Paul Gordon, Andrew Feigin, L. Shulman, Maureen Cook, Brian Wulbrecht, Rajesh Pahwa, T. Foroud, Un Jung Kang, Arthur Watts, Oksana Suchowersky, C. Joubert, J. Vo, Mandar Jog, M. Panisset, Roberta Winnick, Ronald F. Pfeiffer, Barbara Shannon, Jean P. Hubble, Clifford W. Shults, T. Gales, Tanya Simuni, M. Wolff, Hubert H. Fernandez, Pam Andrews, Karyn Boyar, Brad A. Racette, Vicki Hunt, Christine Hunter, Daniel D. Truong, L. Good, Robert L. Rodnitzky, P. Rodriguez, Sandra K. Kostyk, T. Shirley, Cheryl Halter, Peter A LeWitt, W. Weiner, Ryan J. Uitti, Lisa Scollins, Marc L. Gordon, J. Carpenter, Alice Rudolph, Lewis Sudarsky, Robert A. Hauser, Cliff Shults, Bala V. Manyam, Francis O. Walker, Juliette Harris, Marguerite Wieler, K. Dustin, Kelli Williamson, Brenda Pfeiffer, William C. Koller, Frederick J. Marshall, V. Hagen, A. Campbell, B. Hutchinson, L. Elmer, Anja Rudolph, K. Haas, Tori Ross, Rachel Saunders-Pullman, Nathan Pankratz, E. Aiken, Mariann DiMinno, Peggy Roberge, Arif Dalvi, B. Hayward, Mayank Pathak, David Simon, Michael W. Pauciulo, Holly A. Shill, M. Marotta-Kollarus, K. Ligon, Alok Sahay, Joseph H. Friedman, Neal Hermanowicz, E. Julian-Baros, Irenita Gardiner, N. Luong, Danna Jennings, R. Kurlan, and P. M. Conneally
- Subjects
Adult ,Male ,Parkinson's disease ,Adolescent ,Genotype ,Arginine ,Guanine ,Protein Serine-Threonine Kinases ,Biology ,Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 ,medicine.disease_cause ,Diagnosis, Differential ,chemistry.chemical_compound ,Degenerative disease ,medicine ,Humans ,Point Mutation ,Aged ,Aged, 80 and over ,Genetics ,Mutation ,Substitution (logic) ,Adenine Nucleotide Translocator 1 ,Genetic Variation ,Parkinson Disease ,Middle Aged ,medicine.disease ,LRRK2 ,nervous system diseases ,Amino Acid Substitution ,Neurology ,chemistry ,Female ,Neurology (clinical) ,Carrier Proteins - Abstract
Mutations in LRRK2 were first reported as causing Parkinson's disease (PD) in late 2004. Since then, approximately a dozen LRRK2 substitutions have been identified that are believed to be pathogenic mutations. The substitution of adenine for guanine at nucleotide 4541 (4541G>A) in LRRK2 was recently reported. This substitution resulted in the replacement of an arginine at position 1514 with a glutamine (R1514Q). Although this substitution was not found in a large cohort of controls, its pathogenicity could not be verified. We have now genotyped the R1514Q substitution in a sample of 954 PD patients from 429 multiplex PD families. This substitution was identified in 1.8% of the PD patients; however, the majority of the PD sibships segregating this substitution were discordant for this putative mutation. In addition, the R1514Q substitution was detected in 1.4% of neurologically evaluated, control individuals. These data suggest that the R1514Q variant is not a pathogenic LRRK2 mutation. We believe it is imperative that the causative nature of any newly identified genetic variant be determined before it is included in any panel for diagnostic testing.
- Published
- 2007
28. On the possible fractal nature of blazar light curves
- Author
-
A. V. Hagen-Thorn and S. G. Marchenko
- Subjects
Hurst exponent ,Physics ,Astrophysics::High Energy Astrophysical Phenomena ,Fractal dimensionality ,Astronomy and Astrophysics ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics ,Physics::Data Analysis ,Statistics and Probability ,Light curve ,Fractal nature ,Mathematics::Probability ,Range (statistics) ,Detrended fluctuation analysis ,Empirical relationship ,Blazar - Abstract
Optical light curves of three blazars are analyzed by Hurst’s method of normalized range. It is shown that Hurst’s empirical relationship is satisfied for these curves, in accordance with which the Hurst parameters are found for each curve. Assuming that blazar light curves have self-affinity, they determine the fractal dimensionality of the curves to be D ≈ 1.1.
- Published
- 1997
29. [Untitled]
- Author
-
Jürgen Bendig, V. Hagen, and Siegrun Helm
- Subjects
chemistry.chemical_classification ,Quenching (fluorescence) ,Sociology and Political Science ,Base (chemistry) ,Clinical Biochemistry ,Biological activity ,Photochemistry ,Coumarin ,Cleavage (embryo) ,Biochemistry ,Fluorescence ,Clinical Psychology ,chemistry.chemical_compound ,chemistry ,Nucleic acid ,Nucleotide ,Law ,Spectroscopy ,Social Sciences (miscellaneous) - Abstract
We investigated the spectroscopic, photophysical, and photochemical properties of novel caged cyclic nucleotides, the axial and equatorial (7-methoxycoumarin-4-yl)methyl esters of cGMP and of 8-Br-cGMP. The competition between fluorescence and photochemical ester cleavage results in a strong quenching of the coumarin fluorescence. This fluorescence quenching is enhanced additionally by the donor–acceptor interaction between the coumarin unit and the nucleic base, pronounced in the axial configuration. On photochemical decaging the fluorescence intensity increases up to 48-fold and more. This photochemical fluorescence enhancement can be used for the description of the temporal and local distribution of biologically active cGMP derivatives.
- Published
- 1997
30. Synthesis and cardiotonic activity of 6-substituted 5-cyano-(3,4′-bipyridine)-1′-oxides and related compounds: molecular structure of 5-cyano-6-morpholino-(3,4′-bipyridine)-1′-oxide (AWD 122–239)
- Author
-
B. Wiesner, E. Klauschenz, A. Hagen, G Reck, Ernst-Georg Krause, and V Hagen
- Subjects
Pharmacology ,chemistry.chemical_classification ,Morpholino ,Stereochemistry ,Organic Chemistry ,Oxide ,General Medicine ,Crystal structure ,Nitrone ,chemistry.chemical_compound ,Bipyridine ,chemistry ,Peracetic acid ,Drug Discovery ,Pyridine ,Molecule - Abstract
6-Chloro-3,4′-bipyridine-1-oxides 5 and 5-cyano-1,6-dihydro-2-methyl-6-oxo-3,4′-bipyridine-1′-oxide 7 have been prepared from the corresponding pyridine derivatives by oxidation using peracetic acid. Reaction of 5 with various amines gave the 6-substituted compounds 6 . Some of the synthesized products 6 were subsequently converted by derivation into related analogues 8, 9 and 10 . In this series 5-cyano-6-morpholino-(3,4′-bipyridine)-1′-oxide (AWD 122–239, 6a ), exhibited remarkable positive inotropic potency in spontaneously beating isolated guinea-pig atria as well as in anesthetized pigs. Additionally, 6a showed nearly no inhibition of cyclic AMP phosphodiesterase III. The molecular and crystal structures were determined together with the molecular electrostatic potential and structure-activity relationships are discussed. The obtained results clearly indicate compound 6a as a new type of cardiotonic.
- Published
- 1994
31. ChemInform Abstract: Synthesis of 1-Cyano-4-dimethylamino-3-(4-pyridinyl)-1,3-butadiene-1- carboxylic Acid Derivatives and Their Cyclisation to 3-Substituted 2- Amino-5-(4-pyridyl)pyridines Including the Corresponding 1-Oxides
- Author
-
H.‐J. Jaensch and V. Hagen
- Subjects
chemistry.chemical_classification ,chemistry.chemical_compound ,Chemistry ,Carboxylic acid ,Organic chemistry ,1,3-Butadiene ,General Medicine - Published
- 2010
32. ChemInform Abstract: Synthesis of 6-(4-Pyridinyl)-Substituted Pyrido(2,3-d)pyrimidines and 1,8-Naphthyridines
- Author
-
V. Hagen, H. Haber, and M. Schlender
- Subjects
Chemistry ,Organic chemistry ,General Medicine ,Combinatorial chemistry - Published
- 2010
33. ChemInform Abstract: Potential Cardiotonic Drugs. Part 12. 6-(Pyrid-4-yl)-Substituted Pyrido(2,3-d)pyrimidines
- Author
-
V. Hagen, E. Klauschenz, A. Hagen, and A. Knoll
- Subjects
Chemistry ,Cardiotonic drugs ,Organic chemistry ,General Medicine - Published
- 2010
34. ChemInform Abstract: Potential Cardiotonic Agents. Part 10. Synthesis and Positive Inotropic Activity of 5-(4-Pyridinyl)- and 5-Phenyl-Substituted 2- Alkylthio-3-cyanpyridines and Their S-Oxidation Products
- Author
-
V. Hagen, A. Rumler, and A. Hagen
- Subjects
Inotrope ,Chemistry ,General Medicine ,Cardiotonic Agents ,Combinatorial chemistry ,S oxidation - Published
- 2010
35. ChemInform Abstract: Potential Cardiotonic Agents. Part 11. Synthesis and Cardiovascular Properties of 6-Alkyl-Substituted 2-Aminocyano-5-(pyrid-4-yl)pyridines
- Author
-
V. Hagen, E. Klauschenz, S. Heer, and A. Hagen
- Subjects
chemistry.chemical_classification ,Chemistry ,Organic chemistry ,General Medicine ,Cardiotonic Agents ,Alkyl - Published
- 2010
36. ChemInform Abstract: Potential Cardiotonics. Part 18. Synthesis and Cardiotonic Activity of 6-Substituted-5-cyano-(3,4′-bipyridine)-1′-oxides and Related Compounds: Molecular Structure of 5-Cyano-6-morpholino-(3,4′- bipyridine)-1′oxide (AWD 122-239)
- Author
-
V. Hagen, B. Wiesner, Ernst-Georg Krause, A. Hagen, E. Klauschenz, and G. Reck
- Subjects
chemistry.chemical_compound ,Bipyridine ,Morpholino ,Chemistry ,Oxide ,Molecule ,General Medicine ,Combinatorial chemistry - Published
- 2010
37. ChemInform Abstract: Potential Cardiotonic Agents. Part 17. Molecular Electrostatic Potential of 3-Cyano-2-morpholino-5-(4-pyridinyl)pyridine (AWD 122-14)
- Author
-
G. Reck, D. Labes, and V. Hagen
- Subjects
chemistry.chemical_compound ,chemistry ,Morpholino ,Pyridine ,Organic chemistry ,General Medicine ,Cardiotonic Agents ,Combinatorial chemistry - Published
- 2010
38. Overview: Present Developments in Cardiotonic Agents
- Author
-
V. Hagen
- Subjects
Pharmacology ,business.industry ,Medicine ,Cardiotonic Agents ,business - Published
- 1991
39. Synthese von 6-(pyrid-4-yl)-substituierten Pyrido[: 3-d]pyrimidinen und 1,8-Naphthyridinen
- Author
-
V. Hagen, M. Schlender, and H. Haber
- Subjects
chemistry.chemical_classification ,chemistry.chemical_compound ,Pyrimidine ,Chemistry ,Stereochemistry ,Carboxylic acid ,Melting point ,Alkylation ,Ring (chemistry) ,Saponification ,Diethyl oxalate ,Diethyl malonate - Abstract
Synthesis of 6-(4-pyridinyI)-substituted Pyrido[2,3-d]pyrimidines and 1,8-Naphthyridinms A series of new 6-(4-pyridinyl)-substituted pyrido-[2,3-d]pyrimidines 2–4and 1,8-naphthyridines 6, respectively, is described. Cyclisation of 2-amino-5-(4-pyridinyl)-pyridinm-3-carboxamide 1a with diethyl oxalate gives the pyrido-[2,3-d]pyrimidinm 2a. Alkylation of(2a) yields the 3-ethylaminoxyrido[2,3-d]pyrimidine derivative 2b. Saponification of 2a,b gives the corresponding carboxylic acids 3a,b, which are decarboxylated by heating above the melting point to give 4a, b. The 2-amino-5-(4-pyridinyl)-pyridinm carboxylic acid derivatives 1 b–e react with ethylmalonylchloridm and diethyl malonate to afford the 1,8-naphthyridines 6b–e. The 1-oxide 7 in a similar reaction gives 8 and the oxdiazole(9) which is converted by ring transformation to the 1,8-naphthyridine 10.
- Published
- 1991
40. Darstellung von 1-Cyan-4-dimethylamino-3-(pyrid-4-yl)-buta-1,3-dien-1-carbonsäure-Derivaten und ihre Cyclisierung zu 3-substituierten 2-Amino-5-(pyrid-4-yl)-pyridinen sowie den entsprechenden 1-Oxiden
- Author
-
V. Hagen and H.‐J. Jänsch
- Subjects
chemistry.chemical_classification ,chemistry.chemical_compound ,Ammonia ,Hydroxylamine ,chemistry ,Cyanoacetic acid ,Salt (chemistry) ,Organic chemistry ,Phosphorus trichloride ,Medicinal chemistry - Abstract
Synthesis of 1-Cyano-4-dimethylamino-3-(4-pyridinyl)-1,3-butadiene-1-carboxylic Acid Derivatives and Their Cyclisation to 3-Substituted 2-Amino-5-(4-pyridinyl)-pyridines Including the Corresponding 1-Oxides The vinylogous amidinium salt 1 is transformed to 1-cyano-4-dimethylamino-3-(4-pyridinyl)-1,3-butadiene-1-carboxylic acid derivatives 3a-f by reaction with the cyanoacetic acid compounds 2a-f in the presence of bases. Treatment of the 3a-f with ammonia and hydroxylamine yields the 2-amino-5-(4-pyridinyl)-pyridine-3-carboxylic acid derivatives 5a-f and the corresponding 1-oxides 6a-f, respectively. The products 5d, e are also prepared via the 6d, e by reduction with phosphorus trichloride.
- Published
- 1990
41. The effect of dibenzofuran substitutions in corticotropin-releasing factor
- Author
-
M. Dathe, Birgit Roloff, Michael Beyermann, Jens Furkert, Michael Bienert, H. Fabian, K. Fechner, and V. Hagen
- Subjects
Dibenzofuran ,chemistry.chemical_compound ,Biochemistry ,chemistry ,Peptidomimetic ,Biological property ,Pharmacology toxicology ,Molecular medicine ,Protein secondary structure - Abstract
As β-turn-inducing motif, 4-(N-Fmoc-2-aminoethyl)-6-dibenzofuranpropionic acid was synthesized and incorporated into the corticotropin-releasing factor. The effect on structural and biological properties was investigated.
- Published
- 1995
42. A new sarcomatoid variant of multiple myeloma in a 20-year-old male
- Author
-
I. C. Gauer, V. Hagen, and H. Merz
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Lung ,Hematology ,Sarcoma ,General Medicine ,Biology ,medicine.disease ,Cell morphology ,Therapeutic trial ,Disseminated aspergillosis ,medicine.anatomical_structure ,Internal medicine ,medicine ,Humans ,Bone marrow ,Stem cell ,Multiple Myeloma ,Multiple myeloma - Abstract
We present a 20-year-old man with a rare variant of multiple myeloma with peculiar spindle cell morphology and sarcomatoid growth. The diagnosis of multiple myeloma was substantiated by clinical examinations. The patient was treated with several therapeutic trials including autologous stem cell support. Unfortunately, he developed a disseminated aspergillosis of the lungs and died of fatal lung bleeding. We recommended that "sarcomatous" multiple myeloma be considered in cases of "unclassifiable" sarcomatous tumors of the bone marrow.
- Published
- 2003
43. Efficient MoM analysis of polarization selective surfaces using trefoil knot arrays
- Author
-
Raj Mittra, Douglas H. Werner, and J. v. Hagen
- Subjects
Physics ,Preconditioner ,Spectral radius ,Forward scatter ,Mathematical analysis ,Torus ,Geometry ,Impedance parameters ,System of linear equations ,Mathematics::Geometric Topology ,Trefoil ,Trefoil knot - Abstract
The electromagnetic properties of (p,q) torus knots consisting of perfectly conducting thin wires were investigated previously. The (2,3) or trefoil knot has the unique property that its forward scattering characteristics depend on the handedness of an incident circularly polarized wave. This property is conserved when placing the knots in an array. We describe an efficient method of moments (MoM) approach that is especially suited for the analysis of arrays comprised of these knots. In the MoM, solving the linear system of equations is the most time consuming part when the number of unknowns becomes large. For certain classes of problems, the use of preconditioning techniques allows us to reduce the solution time considerably. Array-type of structures can be efficiently analyzed when using the block-LU preconditioner, as outlined. Also, we present the spectral radius as a criterion for assessing the convergence of the method. Finally, we apply the block-LU method to investigate the electromagnetic scattering properties of a medium sized array of trefoil knots.
- Published
- 2003
44. Determination of fractional calcium ion current in cyclic nucleotide-gated channels
- Author
-
S, Frings, D H, Hackos, C, Dzeja, T, Ohyama, V, Hagen, U B, Kaupp, and J I, Korenbrot
- Subjects
Patch-Clamp Techniques ,8-Bromo Cyclic Adenosine Monophosphate ,Cyclic Nucleotide-Gated Cation Channels ,Rod Cell Outer Segment ,Transfection ,Models, Biological ,Ion Channels ,Recombinant Proteins ,Cell Line ,Kinetics ,Spectrometry, Fluorescence ,Retinal Rod Photoreceptor Cells ,Animals ,Humans ,Calcium ,Cattle ,Calcium Channels ,Eye Proteins ,Fura-2 ,Cyclic GMP - Published
- 2000
45. Measurement of intracellular Ca2+ changes using novel caged cyclic nucleotides and confocal laser scanning microscopy
- Author
-
V. Hagen and B. Wiesner
- Subjects
Male ,Microscope ,Photochemistry ,Ultraviolet Rays ,Biophysics ,law.invention ,Cell Line ,Cyclic nucleotide ,chemistry.chemical_compound ,law ,Confocal microscopy ,Microscopy ,Animals ,Humans ,Radiology, Nuclear Medicine and imaging ,Nucleotide ,chemistry.chemical_classification ,Radiation ,Microscopy, Confocal ,Radiological and Ultrasound Technology ,Chemistry ,Lasers ,Laser ,Fluorescence ,Spermatozoa ,Cell biology ,Spectrometry, Fluorescence ,Calcium ,Cattle ,Spectrophotometry, Ultraviolet ,Nucleotides, Cyclic ,Intracellular - Abstract
The intention of this study is to explore the applicability of confocal microscopy in conjunction with the use of caged cyclic nucleotide derivatives. The methodological potential of UV laser confocal microscopy has been assessed. It is shown that illumination of a single cell or a small area of a single cell is possible, whereby the intracelluar Ca2+ signal is measured at illuminated and non-illuminated cells. Such measurements do not have a high time resolution because of the specific system parameters. However, with an N2 pulse laser (not part of the standard microscope set-up), Ca2+ signals with a time resolution of around 100 ms have been measured. This facilitates investigation of the kinetics of Ca2+ influx. Intracellular Ca2+ measurements at HEK293 and sperm cells have been made here. For sperm cells the advantages of confocal microscopy are best evidenced in conjunction with the use of caged cyclic nucleotides; a cyclic nucleotide-gated Ca2+ influx at the tail of these cells has thereby been demonstrated for the first time.
- Published
- 1999
46. Applications of caged compounds of hydrolysis-resistant analogs of cAMP and cGMP
- Author
-
U B, Kaupp, C, Dzeja, S, Frings, J, Bendig, and V, Hagen
- Subjects
Photolysis ,Photochemistry ,Hydrolysis ,Ion Channels ,Olfactory Receptor Neurons ,Cell Line ,Solubility ,Drug Design ,Cyclic AMP ,Retinal Cone Photoreceptor Cells ,Animals ,Humans ,Cattle ,Cyclic GMP - Published
- 1998
47. Analysis of Color Variability of BL Lac during the 1997 and 1999 Outbursts
- Author
-
G. O. Temnov, V. A. Hagen-Thorn, S. G. Jorstad, A. V. Hagen-Thorn, and V. M. Larionov
- Subjects
Physics ,Astrophysics::High Energy Astrophysical Phenomena ,Astrophysics::Solar and Stellar Astrophysics ,Astrophysics - Abstract
The analysis of multicolor observations of BL Lac obtained in the 1997 and 1999 outbursts shows that in both cases the spectral energy distribution of the variable source was unchanged in the course of outburst. The sources have power-law spectra with slightly different spectral indices (the spectrum was flatter in the more powerful outburst of 1997). The variable source is most probably of synchrotron nature.
- Published
- 2002
48. IN VIVO IMMUNOSUPPRESSIVE EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN ON INNATE AND ADAPTIVE IMMUNE CELLS INVOLVED IN ALLOGRAFT REJECTION
- Author
-
Shanta Mancham, Zwier M. A. Groothuismink, H.J. Metselaar, Thanyalak Tha-In, Angela S. W. Tjon, Lijckle van der Laan, M. V. Hagen, and Jaap Kwekkeboom
- Subjects
Transplantation ,Immune system ,biology ,business.industry ,Allograft rejection ,In vivo ,Immunology ,biology.protein ,Medicine ,Antibody ,business - Published
- 2010
49. ChemInform Abstract: Potential Cardiotonic Agents. Part 6. Synthesis and Cardiovascular Properties of 5-(4-Pyridinyl)-, 6-Methyl-5-(4-pyridinyl)-, and 6-Methyl-5-phenyl-Substituted 3-Cyano-2-oxaalkoxypyridines
- Author
-
V. Hagen, A. Rumler, Hartmut Niedrich, D. Lohmann, R. Mitzner, A. Hagen, S. Heer, and E. Klauschenz
- Subjects
Chemistry ,General Medicine ,Cardiotonic Agents ,Medicinal chemistry - Published
- 1990
50. ChemInform Abstract: Potential Cardiotonic Agents. Part 4. Synthesis, Cardiovascular Activity, Molecular, and Crystal Structure of 5-Phenyl- and 5-(4-Pyridinyl)-Substituted 2(1H)-Pyridinethiones
- Author
-
D. Labes, G. Reck, A. Hagen, A. Rumler, V. Hagen, and S. Heer
- Subjects
Chemistry ,General Medicine ,Crystal structure ,Cardiotonic Agents ,Combinatorial chemistry - Published
- 1990
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.